TSS
NRXPW

Two Sigma Securities’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Two Sigma Securities’s Portfolio NRXPW Stock Details NRXPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,400
Closed -$783 – 2700
2024
Q3 		$783 Buy
+17,400
New +$1.28K ﹤0.01% 2720

Other funds holding NRXPW

Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Two Sigma Securities's NRXPW Position: Q4 2024 in Review

Two Sigma Securities sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q4 2024, closing a stake of 17,400 shares — an estimated $783 sold.

Two Sigma Securities first reported a position in NRXPW in Q3 2024 and held it in 1 quarter. The position peaked at $783 in Q3 2024. 5 funds tracked by Wall St. Rank hold NRXPW as of Q4 2024.

  • Two Sigma Securities reported no remaining NRX Pharmaceuticals Warrant position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Securities sold 17,400 NRX Pharmaceuticals Warrant shares in Q4 2024, an estimated $783.
  • Two Sigma Securities first reported a position in NRX Pharmaceuticals Warrant in Q3 2024 and held it in 1 quarter.
  • Two Sigma Securities's NRX Pharmaceuticals Warrant position peaked at $783 in Q3 2024.
  • 5 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.